@misc{oai:repo.qst.go.jp:00063849,
 author = {Kamada, Tadashi and Imai, Reiko and Tsuji, Hiroshi and Suzuki, Motohisa and Okada, Tohru and Sugahara, Shinji and Tsujii, Hirohiko and 鎌田 正 and 今井 礼子 and 辻 比呂志 and 鈴木 志恒 and 岡田 徹 and 菅原 信二 and 辻井 博彦},
 month = {Mar},
 note = {The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2009, a total of 471 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities., II NIRS-CNAO Joint Symposium on Hadrontherapy},
 title = {Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas},
 year = {2010}
}